ProQR Therapeutics BV Free Cash Flow Generation Index

Latest as of March 2023: 1.00x

ProQR Therapeutics BV free cash flow generation index. ProQR Therapeutics BV (PRQR) has a Free Cash Flow Generation Index of 1.00x as of March 2023. Free cash flow of $44.59 Million represents 1% of operating cash flow ($44.73 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$44.59 Million
USD

Operating Cash Flow

$44.73 Million
USD

Capital Expenditures

$136.00K
USD

Free Cash Flow Generation Index of ProQR Therapeutics BV (2023–2023)

Free cash flow generation index of ProQR Therapeutics BV from 2023 to 2023. Historical FCF Generation Index trend for ProQR Therapeutics BV across 1 annual periods. See how financially flexible is ProQR Therapeutics BV to measure the company's free cash flow as a share of total liabilities.

ProQR Therapeutics BV Free Cash Flow Generation Index by Year (2023–2023)

ProQR Therapeutics BV free cash flow generation index by year from 2023 to 2023. Year-by-year Free Cash Flow Generation Index for ProQR Therapeutics BV. For the full cash flow conversion analysis, see ProQR Therapeutics BV operating cash flow efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.94x $20.18 Million $21.55 Million $1.37 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).